Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Cells maintained long term with iCRT3 show enhanced expression of classic pluripotency genes compare with the DMSO control
1 or 2 mg/kg
targeting Akt1
6(11):e27306
Solubility: DMSO: 155 mg/mL(200
Gilteritinib - CAS# 1254053-43-4 Catalog No.:M8549-10 Cells maintained long term withGilteritinib, also known as ASP2215, is a potent FLT3 AXL inhibitor, which showed potent antileukemic activity against AML with either or both FLT3 ITD and FLT3 D835 mutations. In invitro, among the 78 tyrosine kinases tested, ASP2215 inhibited FLT3, LTK, ALK, and AXL kinases by over 50% at 1 nM with an IC50 value of 0. 29 nM for FLT3, approximately 800 fold more potent than for c KIT, the inhibition of which is linked to a potential risk of